Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non-small Cell Lung Cancer Metastatic × sotorasib × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 24 Lung Neoplasms 11 Neoplasms 4 Neoplasm Metastasis 2 Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation 2 Venous Thromboembolism 1 Thoracic Neoplasms 1 Solid Tumor 1 Sexual Dysfunction, Physiological 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Noonan Syndrome 1 Non-small Cell Lung Cancer Metastatic 1 Non Small Lung Cancer 1 Neoplasms by Site 1 Lung Diseases 1 KRAS p, G12c Mutated /Advanced Metastatic NSCLC 1 Hereditary Sensory and Autonomic Neuropathies 1 Eunuchism 1 Erectile Dysfunction 1 Carcinoma 1 Bronchial Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

pembrolizumab 3 Bevacizumab 3 tusamitamab ravtansine 2 Ramucirumab 2 Pemetrexed 2 Gemcitabine 2 Erlotinib Hydrochloride 2 Docetaxel 2 Carboplatin 2 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 2 vistusertib 1 vandetanib 1 telomerase reverse transcriptase p572Y, human 1 spartalizumab 1 sotorasib 1 olaparib 1 necitumumab 1 icotinib 1 durvalumab 1 dacomitinib 1 capivasertib 1 aumolertinib 1 Vinorelbine 1 Radiosurgery 1 Platinum 1 Paclitaxel 1 MLN 8237 1 LY3023414 1 Injections 1 GC Temporary Stopping 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06127940 2023-11-13

K-SAB

Karolinska University Hospital

Phase 1 Unknown

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡